floatz AI
AI-powered platform for drug discovery, identifying high-potential therapeutic targets with precision.
About floatz AI
floatz AI accelerates drug discovery by identifying promising targets based on human genetics, gene expression, and biological pathways. It integrates diverse data sources to map billions of concepts, enabling the rapid prioritization of targets with high translational potential. The platform delivers three clinically-relevant targets within 14 days, supporting efficient therapeutic development.
How to Use
Define your therapeutic focus, such as disease area, indication, and specific constraints. floatz analyzes literature, disease biology, omics data, and pathway networks to generate a comprehensive opportunity map. It then curates three top targets with scientific rationale, supporting data, and expert review, delivering a decision-ready PDF within 14 days.
Features
- Comprehensive multi-source analysis including literature, omics, and pathway data
- Rapid delivery of three clinically-relevant targets within 14 days
- AI-enabled identification of drug targets
- Integration of genetics, tissue expression, and pathway insights
- Expert-reviewed and validated target selection
Use Cases
- Guiding strategic decisions and licensing evaluations in drug development
- Discovering novel therapeutic targets for specific diseases
- Expanding existing drug pipelines or exploring new treatment areas
Best For
Pros
- Satisfaction guarantee with credit toward revisions
- Full refund if not delivered within 14 days
- Twice as fast as internal review processes
- Exclusive access to generated targets
- High-confidence, ready-to-advance targets
- Data-driven approach eliminates guesswork
- Customizable constraints such as modality or target class
- Confidential, client-specific reports
- Targets grounded in robust, multi-layered data
Cons
- Pricing details are not publicly disclosed
- Deliverables are in PDF format, not an interactive platform